Skip to content

Compare of Nux vomica 6c versus individualized homoeopathic medicines in treatment of people with functional dyspepsia

In vitro antioxidant activity of Nux vomica 6C and open label randomised clinical trial to evaluate the effectiveness of Nux vomica 6C in comparison with individualised homoeopathic medicines in functional dyspepsia: an integrative study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097521
Enrollment
128
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: individualized homoeopathic medicine: dose and frequency will be selected as per the susceptibility of the case. follow up will be done monthly till 3 months from the baseline Control I

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age between 18 to 60 years Both sexes and all religions 2 Individuals who provide written informed consent 3 Females who are not pregnant or breastfeeding during the course of the study 4 Patients not currently taking any other treatment allopathic or homeopathic for dyspepsia 5 Patients who are otherwise clinically stable and fit to participate in the study 6 Individuals willing to adhere to follow-up visits and treatment protocol 7 Patients who are eligible to read Bengali English Hindi 8 Patients diagnosed clinically by DSSI score above 15

Exclusion criteria

Exclusion criteria: 1 Age below 18 and above 60 2 Pregnancy and Malignancy 3 Known case of cardiac and liver diseases 4 Patients on going treatment with corticosteroids immune suppressants 5 Patients suffering from any severe psychiatric illness 6 Patients not willing to give written consent 7 Patients diagnosed clinically by DSSI score below 15

Design outcomes

Primary

MeasureTime frame
evaluate the antioxidant activity of nux vomica 6c by using antioxidant assays and the response of the patients will be observed by changes in the DSSI score before and after intervention in assessed Timepoint: Baseline and 3 months

Secondary

MeasureTime frame
: evaluate pre and post intervention changes of the quality of life of the patients by using SF-NDITimepoint: baseline and 6 months

Countries

India

Contacts

Public ContactDr kumaravel V

National Institute of Homoeopathy

drkumaravelnih@gmail.com9748163274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026